PRESS RELEASE
A resounding success for Visiomed Group’s participatory bond issue
which reached €3.6 million
Paris, August 22, 2022
VISIOMED GROUP (FR0013481835 – ALVMG), a group dedicated to innovative health technologies and services, announces the great success of its participatory bond issue.
On July 12, VISIOMED GROUP announced the launch of the first participatory bond issue carried out by a company listed on Euronext Growth in Paris, with a fundraising objective of at least €2.5 million. July 29; this amount had been reached in just 16 days. On August 16, when the amount of subscriptions exceeded €3.3 million, VISIOMED GROUP announced an extension of the subscription period to respond to the request of certain identified investors requiring additional banking time. The amount subscribed via the Equisafe Invest platform at closing thus reached €3.6 million.
A total of 3,640,592 bonds, with a nominal unit value of €1.00, were issued and subscribed by 486 investors. They have a maturity of 2 years, are redeemable in fine at par and carry an annual interest rate of 10.5% payable on each anniversary.
VISIOMED GROUP will rely on this financing to pursue its development strategy as presented in its plan of May 25, 2022
[1]
and during the hosted webinar on June 29, 2022
[2]
while respecting its commitments to use non-dilutive sources of financing:
The acceleration of the expansion of Smart Salem with the opening of two new centers before the end of the year
[3]
while the 1
er
center experienced record attendance in June 2022[4]
;
The repositioning of BewellConnect;
Activation of synergies and external growth opportunities.
Thomas Picquette, Managing Director of VISIOMED GROUP, declares:
“The very large success, well beyond our expectations, of this first participatory bond issue carried out by a company listed on Euronext Growth in Paris testifies to the confidence that we are in the process of rebuilding with investors thanks to a clear and ambitious and with solid fundamentals. I would like to thank each investor as well as our partner Equisafe Invest who made this operation possible. »
Warning
This issue will not give rise to a Prospectus approved by the AMF.
Risk factors
The attention of the public is drawn to the risk factors relating to the company and its activity, described in the 2021 Annual Financial Report available on the Company’s website (www.visiomed.fr). The realization of all or part of these risks is likely to have an unfavorable effect on the activity, the financial situation, the results, the development or the prospects of the company.
About VISIOMED GROUP
Founded in 2007, VISIOMED GROUP develops and markets innovative health products and services focused on uses. Its mission: to put innovation at the service of the health of all, starting from the needs of each one. BewellConnect®, its connected health subsidiary, today concentrates all the know-how of VISIOMED GROUP in terms of e-health for the general public as well as for players in the world of health with a complete ecosystem of solutions that improve prevention. , treatment and medical follow-up. It has developed and markets in particular
VisioCheck®
the 1
time
mobile and connected teleconsultation station weighing less than 300 grams.
In August 2021, VISIOMED GROUP acquired
Smart Salem
(smartsalem.ae), the only medical center digitized and accredited by the Dubai Ministry of Health (DHA) as well as the General Directorate of Residence and Foreign Affairs (GDRFA) in the United Arab Emirates.
Based in Paris, VISIOMED GROUP is listed on Euronext Growth (ALVMG). More information on visiomed-group.com and www.bewell-connect.com
CONTACTS
Jérôme FABREGUETTES-LEIB | Fatou-Kine N’DIAYE |
Investor Relations | Financial Press Relations |
Phone: 01 53 67 36 78 | Tel: 01 53 67 36 34 |
© Visiomed Group SA 2022. The brands mentioned are the property of their respective authors. Reproduction prohibited, even partial, without prior authorization.
Warning
This release contains non-factual materials, including, but not limited to, certain statements regarding future results and other future events. These statements are based on the current view and assumptions of the Company’s management. They incorporate known and unknown risks and uncertainties that could cause actual results, profitability and expected events to differ materially. Furthermore, VISIOMED GROUP, its shareholders and its respective affiliates, directors, officers, counsel and employees have not verified the accuracy of, and make no representations or warranties about, the statistical information or the forward-looking information contained in this release that are or are derived from third party sources or industry publications. These statistical data and forward-looking information are used in this press release for informational purposes only.
[1]
Link to the presentation: https://www.actusnews.com/documents/ACTUS-0-12384-visiomed-group-sa-presentation-du-plan-strategique.pdf
[2]
Link to the replay: https://visiomed.fr/videoconference-de-presentation-du-plan-strategique-29-juin-2022/
[3]
Smart Salem: signature of the framework contract with the Dubai Health Authority (DHA) for the opening of the 3
th
center
[4]
Attendance record for Smart Salem in June 2022
This post has the “? Actusnews SECURITY MASTER” service.
– SECURITY MASTER Key:
nGltZcdokpuXlWxrk51tbmVsbmxqyJaVammalGdrlpmWmJ2SmGdiaJbIZnBmnmxr
– To check this key:
https://www.security-master-key.com.
Regulated information:
Inside information:
– Other press releases
Full and original press release in PDF format:
https://www.actusnews.com/news/75975-cp_alvmg_cip_equisafe_closing-final.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com